Apogee Therapeutics shares owned by Blackstone Group
Quarter-by-quarter ownership of Apogee Therapeutics (APGE) shares owned by Blackstone Group
from 13F filings
Historical chart of Blackstone Group investment in Apogee Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Apogee Therapeutics held by Blackstone Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Apogee Therapeutics by Blackstone Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $7.6M | 190k | 39.73 |
| 2025-06-30 | $7.8M | 179k | 43.43 |
| 2025-03-31 | $6.9M | 184k | 37.36 |
| 2024-12-31 | $3.6M | 80k | 45.30 |
| 2024-09-30 | $4.7M | 80k | 58.74 |
| 2024-06-30 | $3.1M | 80k | 39.35 |
| 2024-03-31 | $15M | 230k | 66.45 |
| 2023-12-31 | $9.8M | 352k | 27.94 |
| 2023-09-30 | $6.4M | 299k | 21.30 |